IPC The Hospitalist (Nasdaq: IPCM) reported earnings on July 25. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended June 30 (Q2), IPC The Hospitalist missed estimates on revenues and missed slightly on earnings per share.

Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share grew significantly. GAAP earnings per share grew significantly.

Gross margins grew, operating margins dropped, net margins increased.

Revenue details
 IPC The Hospitalist reported revenue of $145.8 million. The 11 analysts polled by S&P Capital IQ looked for revenue of $149.6 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $128.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.53. The 13 earnings estimates compiled by S&P Capital IQ averaged $0.54 per share. Non-GAAP EPS of $0.53 for Q2 were 15% higher than the prior-year quarter's $0.46 per share. GAAP EPS of $0.71 for Q2 were 54% higher than the prior-year quarter's $0.46 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 26.9%, 10 basis points better than the prior-year quarter. Operating margin was 10.1%, 10 basis points worse than the prior-year quarter. Net margin was 8.4%, 230 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $148.2 million. On the bottom line, the average EPS estimate is $0.53.

Next year's average estimate for revenue is $604.7 million. The average EPS estimate is $2.20.

Investor sentiment
 The stock has a five-star rating (out of five) at Motley Fool CAPS, with 70 members out of 73 rating the stock outperform, and three members rating it underperform. Among 19 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 19 give IPC The Hospitalist a green thumbs-up, and give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on IPC The Hospitalist is hold, with an average price target of $46.75.

Is IPC The Hospitalist the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.